BORIS NIKOLIC, M.D.
Dr. Nikolic completed postdoctoral training in transplantation immunology at Harvard Medical School and served as an assistant professor of medicine at Massachusetts General Hospital/Harvard Medical School. He has authored more than 70 articles, patents and patent applications, and has co-founded several biotechnology companies that have since been acquired. Dr. Nikolic earned his M.D. from University of Zagreb School of Medicine in Croatia, and clinical training at University Hospital Centre in Zagreb.
Dr. Nikolic sits on the Board of Directors for several of Biomatics’ portfolio companies including Encodia, eGenesis, Omniome and GuideRx. He is a board observer for Cytrellis, Verve and Thrive.